6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderActive, not recruitingPhase 32026-09-04NCT04821622
Preoperative Proton Irradiation for High-grade Brain Gliomas.High Grade GliomasRecruitingPhase 12026-07-17NCT07710040
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayercancer, neoplasmActive, not recruitingPhase 32026-07-07NCT04464226
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)Metastatic Castrate Resistant Prostate Cancer (mCRPC)Active, not recruitingPhase 42026-07-06NCT04597125
OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic SitesNeoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic neoplasm, neoplasmRecruitingPhase 22025-03-04NCT06856603
Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative CareOligometastatic DiseaseRecruitingPhase 2 / Phase 32024-08-16NCT06556550